Clinical Overview of MDM2/X-Targeted Therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Overview of MDM2/X-Targeted Therapies

Published:2016-01-27 Issue: Volume:6 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Burgess Andrew,Chia Kee Ming,Haupt Sue,Thomas David,Haupt Ygal,Lim Elgene

Funder

Cancer Institute NSW

National Health and Medical Research Council

National Breast Cancer Foundation

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference64 articles.

1. Restoration of p53 function leads to tumour regression in vivo;Ventura;Nature,2007

2. Modeling the therapeutic efficacy of p53 restoration in tumors;Martins;Cell,2006

3. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas;Xue;Nature,2007

4. Mutant p53 reactivation by small molecules makes its way to the clinic;Bykov;FEBS Lett,2014

5. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal;Gao;Sci Signal,2013

Cited by 277 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Ubiquitin-specific proteases as therapeutic targets in Glioblastoma;Pathology - Research and Practice;2024-08

2. TRIM47 silencing inhibits the malignant biological behaviors of prostate cancer cells by regulating MDM2/p53 signaling;Cell Biochemistry and Biophysics;2024-05-27

3. Xinnaotongluo liquid protects H9c2 cells from H/R-induced damage by regulating MDM2/STEAP3;PLOS ONE;2024-04-19

4. Nanoencapsulation of MDM2 Inhibitor RG7388 and Class-I HDAC Inhibitor Entinostat Enhances their Therapeutic Potential Through Synergistic Antitumor Effects and Reduction of Systemic Toxicity;Molecular Pharmaceutics;2024-02-09

5. Advancements in the diagnosis, prognosis, and treatment of retinoblastoma;Canadian Journal of Ophthalmology;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3